Development of a traditional Chinese medicine‐based agent for the treatment of cancer cachexia
出版年份 2022 全文链接
标题
Development of a traditional Chinese medicine‐based agent for the treatment of cancer cachexia
作者
关键词
-
出版物
Journal of Cachexia Sarcopenia and Muscle
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2022-06-20
DOI
10.1002/jcsm.13028
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle : update 2021
- (2021) Stephan Haehling et al. Journal of Cachexia Sarcopenia and Muscle
- Indoprofen prevents muscle wasting in aged mice through activation of PDK1/AKT pathway
- (2020) Hyebeen Kim et al. Journal of Cachexia Sarcopenia and Muscle
- Phytotherapy for Cachexia: Where Do We Stand?
- (2020) Kenny Kuchta et al. Frontiers in Pharmacology
- Animal models of sarcopenia
- (2020) Courtney J. Christian et al. AGING CELL
- Effects of a rhizome aqueous extract of Dioscorea batatas and its bioactive compound, allantoin in high fat diet and streptozotocin-induced diabetic mice and the regulation of liver, pancreas and skeletal muscle dysfunction
- (2020) Junnan Ma et al. JOURNAL OF ETHNOPHARMACOLOGY
- Network Pharmacology Databases for Traditional Chinese Medicine: Review and Assessment
- (2019) Runzhi Zhang et al. Frontiers in Pharmacology
- A behavior-based drug screening system using a Caenorhabditis elegans model of motor neuron disease
- (2019) Kensuke Ikenaka et al. Scientific Reports
- Modeling Human Cancer-induced Cachexia
- (2019) Erin E. Talbert et al. Cell Reports
- UNC-120/SRF independently controls muscle aging and lifespan in Caenorhabditis elegans
- (2018) Adeline Mergoud dit Lamarche et al. AGING CELL
- Cancer-associated cachexia
- (2018) Vickie E. Baracos et al. Nature Reviews Disease Primers
- Effects of Rhizome Extract of Dioscorea batatas and Its Active Compound, Allantoin, on the Regulation of Myoblast Differentiation and Mitochondrial Biogenesis in C2C12 Myotubes
- (2018) Junnan Ma et al. MOLECULES
- Prevention of oral carcinogenesis in rats by Dracaena cinnabari resin extracts
- (2018) Nashwan Al-Afifi et al. Clinical Oral Investigations
- Actinidia chinensis Planch root extract attenuates proliferation and metastasis of hepatocellular carcinoma by inhibiting epithelial-mesenchymal transition
- (2018) Tingting Fang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Targeting breast cancer stem cells by novel HDAC3-selective inhibitors
- (2017) Hao-Yu Hsieh et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugs
- (2017) Wooseong Kim et al. Expert Opinion on Drug Discovery
- Modified forelimb grip strength test detects aging-associated physiological decline in skeletal muscle function in male mice
- (2017) Hikari Takeshita et al. Scientific Reports
- Comparative Analysis of Proteins with Stimulating Activity on Ovarian Estradiol Biosynthesis from Four Different Dioscorea Species in vitro Using Both Phenotypic and Target-based Approaches: Implication for Treating Menopause
- (2016) J. Lu et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- Screening lifespan-extending drugs in Caenorhabditis elegans via label propagation on drug-protein networks
- (2016) Hui Liu et al. BMC Systems Biology
- Moutan cortex extract exerts protective effects in a rat model of cardiac ischemia/reperfusion
- (2016) Hong Dan et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Use of ghrelin in cachexia syndrome: a systematic review of clinical trials
- (2016) Jéssica V. Mansson et al. NUTRITION REVIEWS
- Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases
- (2015) Xi Chen et al. Chemistry Central Journal
- A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia
- (2015) Danielle N. Seto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia
- (2015) Yu-Chou Tseng et al. JNCI-Journal of the National Cancer Institute
- Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: An in vitro and in vivo study
- (2015) LEI YUAN et al. ONCOLOGY REPORTS
- Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia
- (2015) Yu-Chou Tseng et al. JNCI-Journal of the National Cancer Institute
- C. elegans in high-throughput drug discovery
- (2013) Linda P. O'Reilly et al. ADVANCED DRUG DELIVERY REVIEWS
- Functional Aging in the Nervous System Contributes to Age-Dependent Motor Activity Decline in C. elegans
- (2013) Jie Liu et al. Cell Metabolism
- An In Vivo C. elegans Model System for Screening EGFR-Inhibiting Anti-Cancer Drugs
- (2012) Young-Ki Bae et al. PLoS One
- Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse
- (2010) Paola Aulino et al. BMC CANCER
- Interleukin 6 as a Key Regulator of Muscle Mass during Cachexia
- (2010) James A. Carson et al. EXERCISE AND SPORT SCIENCES REVIEWS
- C2 and C2C12 murine skeletal myoblast models of atrophic and hypertrophic potential: Relevance to disease and ageing?
- (2010) Adam P. Sharples et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Interleukin-1 stimulates catabolism in C2C12 myotubes
- (2009) Wei Li et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More